查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1961420

玻片染色劑市場－全球產業規模、佔有率、趨勢、機會、預測：依產品、技術、最終用戶、地區和競爭格局分類，2021-2031年

Slide Stainers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Reagent,Equipment), By Technique, By End user, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球玻片染色設備市場預計將從 2025 年的 48.7 億美元成長到 2031 年的 66.9 億美元，複合年成長率為 5.43%。

玻片染色系統是一種自動化實驗室儀器，用於對玻璃載玻片上的細胞和組織樣本進行染色，從而提高顯微鏡觀察和疾病診斷的對比。市場成長的主要驅動力是全球慢性病（包括癌症）發生率上升導致切片檢查檢測量顯著增加。此外，為減少人為錯誤、提高工作流程效率以及解決熟練組織病理學家嚴重短缺的問題，實驗室自動化需求的不斷成長也是推動市場成長的因素之一。

市場概覽
預測期 2027-2031
市場規模：2025年 48.7億美元
市場規模：2031年 66.9億美元
複合年成長率：2026-2031年 5.43%
成長最快的細分市場 試劑
最大的市場 北美洲

另一方面，這些設備的購買和維護成本高昂，常常為發展中地區的小規模實驗室和醫療機構的預算帶來沉重負擔，阻礙了市場成長。例如，美國癌症協會報告稱，預計到2024年，美國新增癌症病例數將首次超過200萬例，顯示市場需求正在增加。病例數的增加凸顯了對高通量染色解決方案的迫切需求，以維持及時、準確的診斷流程。

市場促進因素

慢性疾病和感染疾病率的上升是全球玻片染色設備市場的主要驅動力，從根本上增加了準確診斷所需的組織分析量。隨著癌症等疾病在全球的流行，臨床檢查室必須應對複雜的切片檢查樣本工作量，這些樣本需要嚴格的染色才能進行顯微鏡檢查。診斷需求的激增需要能夠快速、穩定地處理大量玻片的高通量染色系統，從而縮短關鍵患者報告的周轉時間。根據《採血針》 2025年9月的一項調查，預計到2050年，全球癌症病例將超過3000萬例，比2024年成長60%。這種情況凸顯了先進自動化染色設備的緊迫性，這些設備能夠在不影響品質的前提下保持高日處理能力。

同時，熟練的組織病理學家和技術人員嚴重短缺，加速了檢查室自動化技術的應用，並正在改變市場模式。為了應對勞動力短缺問題，自動化切片染色系統正在逐步推廣，消除人工操作的差異，使有限的人員能夠專注於高價值的診斷工作。根據英國英國病理學院2025年6月發布的報告，78%的受訪病理學家表示「目前的員工數量不足以滿足日益成長的臨床需求」。因此，檢查室正在整合數位病理工具和自動化系統，以建立無縫的工作流程。例如，徠卡生物系統公司於2025年1月宣布對Indica Labs進行策略性投資，以加速人工智慧驅動的伴隨診斷技術的發展，顯示整個產業正向完全整合的自動化解決方案轉型。

市場挑戰

自動化玻片染色系統高昂的購置和維修成本對小規模檢查室和醫療機構構成了顯著的進入門檻，嚴重限制了市場成長。這些機構通常資金儲備有限，難以承擔先進染色平台所需的大量前期投資。因此，許多機構被迫延長老舊設備的使用壽命，或繼續依賴人工操作，這直接降低了新設備的銷售周轉率，並限制了製造商的潛在市場規模。

這種財務壓力迫使決策者優先考慮必要的營運支出而非資本投資，導致技術應用停滯不前。資產管理策略調整也反映了這種限制的嚴重性。根據美國醫院協會 (AHA) 2025 年的一項調查，94% 的醫療機構管理者預計會推遲設備升級以應對財務負擔。由於預算限制而對新技術投資的猶豫，直接阻礙了醫療產業充分利用診斷自動化日益成長的需求。

市場趨勢

多重染色技術的引入正在從根本上改變市場格局，它能夠同時檢測單一組織切片上的多種生物標記物，突破了傳統單標記物免疫組化技術的局限性。這項技術在腫瘤免疫學領域的重要性日益凸顯，因為了解腫瘤微環境中免疫細胞複雜的空間分佈對於制定有效的治療方案至關重要。與僅以速度為導向的標準高通量儀器不同，這些先進平台能夠最大限度地從有限的切片檢查組織中獲取數據，從而實現更深入的表現型分析。太空生物學系統的日益普及清楚地反映了這項技術的商業性勢頭。根據Akoya Biosciences公司統計，截至2024年11月，全球太空分析系統的安裝量已達1,299套，年成長15%，凸顯了該產業正迅速向高度複雜的染色技術轉型。

同時，伴隨診斷染色通訊協定的擴展正在改變整個行業，製藥公司擴大將標靶治療與特定的自動化染色檢測相結合。這一趨勢需要開發封閉式染色設備，以確保嚴格的監管合規性和檢測的可重複性，而這兩點對於精準醫療中的患者分層至關重要。隨著伴隨必要診斷檢測的新藥獲得核准，檢查室不得不投資這些專用平台，以維持其臨床意義並確保獲得報銷。這種整合的經濟影響顯著，並在許多經濟挑戰中推動了成長。根據羅氏截至2025年1月的會計年度財務報告，診斷業務核心銷售額成長了8%，這一業績顯然歸功於對免疫診斷產品和用於精準診斷的先進染色解決方案的需求不斷成長。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球玻片染色劑市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品組成（試劑（染色劑、封片劑、組織固定劑、處理劑）、設備）
    • 依技術（H&E染色、ISH、IHC、血液學、細胞學）
    • 依最終使用者（醫院/診所、學術/研究機構、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美玻片染色劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲玻片染色劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區載玻片染料市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲玻片染色劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美玻片染色劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球玻片染色劑市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Thermo Fisher Scientific inc.
  • F. Hoffmann-La Roche AG
  • Danaher Corporation
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Abcam plc.
  • Siemens Healthineers
  • General Data Company, Inc.
  • Biocare Medical, LLC

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 22679

The Global Slide Stainers Market is projected to expand from USD 4.87 Billion in 2025 to USD 6.69 Billion by 2031, registering a CAGR of 5.43%. Slide stainers are automated laboratory instruments utilized to color cells or tissue samples on glass slides, thereby improving contrast for microscopic examination and disease diagnosis. The market is primarily propelled by the increasing global prevalence of chronic diseases, especially cancer, which creates a need for a significantly higher volume of biopsy tests. Furthermore, the sector is supported by a growing demand for laboratory automation to reduce manual errors, enhance workflow efficiency, and mitigate the severe shortage of skilled histopathologists.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 4.87 Billion
Market Size 2031USD 6.69 Billion
CAGR 2026-20315.43%
Fastest Growing SegmentReagent
Largest MarketNorth America

Conversely, market growth is hindered by the substantial acquisition and upkeep costs of these instruments, which frequently burden the budgets of smaller laboratories and healthcare facilities in developing areas. To demonstrate the intensity of demand, the American Cancer Society reported that the projected number of new cancer cases in the United States surpassed 2 million for the first time in 2024. This rising caseload emphasizes the critical need for high-throughput staining solutions to maintain timely and precise diagnostic workflows.

Market Driver

The increasing incidence of chronic and infectious diseases acts as a major catalyst for the Global Slide Stainers Market, fundamentally boosting the volume of tissue analysis needed for accurate diagnosis. As the prevalence of conditions like cancer rises globally, clinical laboratories must manage a compounding workload of biopsy samples requiring rigorous staining for microscopic review. This surge in diagnostic demand requires high-throughput staining systems capable of processing large batches of slides quickly and consistently, thereby shortening turnaround times for essential patient reports. According to research from The Lancet in September 2025, global cancer cases are expected to exceed 30 million by 2050, a 60% increase from 2024 levels, highlighting the urgent need for advanced automated stainers that can sustain high daily throughputs without sacrificing quality.

Simultaneously, the accelerating adoption of laboratory automation is transforming the market landscape, largely due to acute shortages of skilled histopathologists and technicians. Automated slide stainers are increasingly deployed to address these workforce constraints, eliminating manual inconsistencies and allowing limited personnel to focus on higher-value diagnostic tasks. In a June 2025 report by the Royal College of Pathologists, 78% of surveyed pathologists stated that current staffing levels are insufficient to meet growing clinical demands. Consequently, laboratories are integrating these automated systems with digital pathology tools to create seamless workflows; for example, Leica Biosystems announced a strategic investment in Indica Labs in January 2025 to accelerate AI-enabled companion diagnostics, reflecting the industry's shift toward fully integrated automated solutions.

Market Challenge

The substantial acquisition and maintenance costs associated with automated slide stainers significantly restrict market growth by creating a high barrier to entry for smaller laboratories and healthcare facilities. These organizations often operate with limited capital reserves, making it difficult to justify the heavy upfront investment required for advanced staining platforms. Consequently, many facilities are forced to prolong the lifespan of legacy equipment or continue relying on manual processes, which directly reduces the turnover rate for new instrument sales and limits the total addressable market for manufacturers.

This financial pressure compels decision-makers to prioritize essential operational expenses over capital improvements, effectively stalling technological adoption. The severity of this constraint is evident in strategic adjustments regarding asset management; according to the American Hospital Association in 2025, 94% of healthcare administrators expected to delay equipment upgrades to manage financial strain. This hesitation to invest in new technology, driven by budgetary limitations, directly hampers the industry's ability to capitalize on the growing demand for diagnostic automation.

Market Trends

The adoption of multiplexing and multi-staining technologies is fundamentally shifting the market by enabling the simultaneous detection of multiple biomarkers on a single tissue slide, surpassing the limitations of traditional single-marker immunohistochemistry. This capability is becoming increasingly critical in immuno-oncology, where understanding the complex spatial arrangement of immune cells within the tumor microenvironment is essential for effective treatment planning. Unlike standard high-throughput units designed solely for speed, these advanced platforms allow laboratories to maximize data yield from limited biopsy tissue, facilitating deeper phenotypic analysis. The growing commercial traction of this technology is evident in the rising deployment of spatial biology systems; according to Akoya Biosciences in November 2024, its global installed base of spatial instruments reached 1,299 units, a 15% increase compared to the prior year, highlighting the sector's rapid pivot toward high-complexity staining.

In parallel, the expansion of companion diagnostic staining protocols is reshaping the industry as pharmaceutical companies increasingly pair targeted therapies with specific automated staining assays. This trend necessitates the development of closed-system stainers that ensure strict regulatory compliance and assay reproducibility, which are non-negotiable for patient stratification in precision medicine. As new drugs are approved with mandatory diagnostic tests, laboratories are compelled to invest in these specialized platforms to maintain clinical relevance and ensure reimbursement. The economic impact of this integration is significant, driving growth even amidst broader economic challenges; according to Roche's January 2025 financial report, the Diagnostics Division achieved an 8% growth in its base business sales, a performance explicitly attributed to the heightened demand for immunodiagnostic products and advanced staining solutions used in precision diagnostics.

Key Market Players

  • Thermo Fisher Scientific inc.
  • F. Hoffmann-La Roche AG
  • Danaher Corporation
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Abcam plc.
  • Siemens Healthineers
  • General Data Company, Inc.
  • Biocare Medical, LLC

Report Scope

In this report, the Global Slide Stainers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Slide Stainers Market, By Product

  • Reagent (Stains, Mounting, Tissue Fixation, Processing)
  • Equipment

Slide Stainers Market, By Technique

  • H&E
  • ISH
  • IHC
  • Hematology
  • Cytology

Slide Stainers Market, By End user

  • Hospitals & Clinics
  • Academic & Research Institutes
  • Others

Slide Stainers Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Slide Stainers Market.

Available Customizations:

Global Slide Stainers Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Slide Stainers Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Reagent (Stains, Mounting, Tissue Fixation, Processing), Equipment)
    • 5.2.2. By Technique (H&E, ISH, IHC, Hematology, Cytology)
    • 5.2.3. By End user (Hospitals & Clinics, Academic & Research Institutes, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Slide Stainers Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Technique
    • 6.2.3. By End user
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Slide Stainers Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Technique
        • 6.3.1.2.3. By End user
    • 6.3.2. Canada Slide Stainers Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Technique
        • 6.3.2.2.3. By End user
    • 6.3.3. Mexico Slide Stainers Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Technique
        • 6.3.3.2.3. By End user

7. Europe Slide Stainers Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technique
    • 7.2.3. By End user
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Slide Stainers Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Technique
        • 7.3.1.2.3. By End user
    • 7.3.2. France Slide Stainers Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Technique
        • 7.3.2.2.3. By End user
    • 7.3.3. United Kingdom Slide Stainers Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Technique
        • 7.3.3.2.3. By End user
    • 7.3.4. Italy Slide Stainers Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Technique
        • 7.3.4.2.3. By End user
    • 7.3.5. Spain Slide Stainers Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Technique
        • 7.3.5.2.3. By End user

8. Asia Pacific Slide Stainers Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technique
    • 8.2.3. By End user
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Slide Stainers Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Technique
        • 8.3.1.2.3. By End user
    • 8.3.2. India Slide Stainers Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Technique
        • 8.3.2.2.3. By End user
    • 8.3.3. Japan Slide Stainers Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Technique
        • 8.3.3.2.3. By End user
    • 8.3.4. South Korea Slide Stainers Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Technique
        • 8.3.4.2.3. By End user
    • 8.3.5. Australia Slide Stainers Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Technique
        • 8.3.5.2.3. By End user

9. Middle East & Africa Slide Stainers Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technique
    • 9.2.3. By End user
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Slide Stainers Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Technique
        • 9.3.1.2.3. By End user
    • 9.3.2. UAE Slide Stainers Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Technique
        • 9.3.2.2.3. By End user
    • 9.3.3. South Africa Slide Stainers Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Technique
        • 9.3.3.2.3. By End user

10. South America Slide Stainers Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Technique
    • 10.2.3. By End user
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Slide Stainers Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Technique
        • 10.3.1.2.3. By End user
    • 10.3.2. Colombia Slide Stainers Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Technique
        • 10.3.2.2.3. By End user
    • 10.3.3. Argentina Slide Stainers Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Technique
        • 10.3.3.2.3. By End user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Slide Stainers Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. F. Hoffmann-La Roche AG
  • 15.3. Danaher Corporation
  • 15.4. Merck KGaA
  • 15.5. Agilent Technologies, Inc.
  • 15.6. Becton, Dickinson and Company
  • 15.7. Abcam plc.
  • 15.8. Siemens Healthineers
  • 15.9. General Data Company, Inc.
  • 15.10. Biocare Medical, LLC

16. Strategic Recommendations

17. About Us & Disclaimer